Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report

Mark E. Wylam, Peter M. Anderson, Nancy L. Kuntz, Vilmarie Rodriguez

Research output: Contribution to journalArticle

96 Scopus citations

Abstract

We report the successful use of anti-CD20 therapy in a child with refractory myasthenia gravis (MG), an antibody-mediated autoimmune disease, who did not respond to conventional therapy. After initiation of anti-CD20 therapy, clinical improvement (muscular strength, pulmonary function) was observed.

Original languageEnglish (US)
Pages (from-to)674-677
Number of pages4
JournalJournal of Pediatrics
Volume143
Issue number5
DOIs
StatePublished - Nov 2003

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report'. Together they form a unique fingerprint.

  • Cite this